Table 4.
Characteristics according to the severe vascular calcifications
| SVCS<2 (n=124) | SVCS≥3 (n=48) | P | |
|---|---|---|---|
| Age, y | 54.7±13.8 | 61.0±11.3 | 0.003 |
| Sex (male) | 59 (47.6%) | 27 (56.3%) | 0.395 |
| Body weight (kg) | 59.4±10.8 | 61.0±8.1 | 0.301 |
| Height (m) | 1.60±0.08 | 1.60±0.08 | 0.923 |
| BMI (kg/m2) | 22.5 (20.8–25.2) | 223.1 (22.0–25.0) | 0.125 |
| Hemodialysis | 58 (46.8%) | 26 (54.2%) | 0.401 |
| Dialysis duration (mo) | 34.5 (19.0–67.0) | 40.5 (16.0–62.5) | 0.782 |
| Comorbidities | |||
| Diabetes mellitus | 34 (27.4%) | 40 (83.3%) | 0.000 |
| Hypertension | 108 (87.1%) | 44 (91.7%) | 0.596 |
| Ischemic heart disease | 9 (7.3%) | 6 (12.5%) | 0.365 |
| COPD | 3 (2.4%) | 4 (8.3%) | 0.096 |
| Intact parathyroid hormone (pg/mL) | 237.2 (147.9–419.7) | 123.4 (71.1–293.0) | 0.001 |
| Intact parathyroid hormone group (150–300) | |||
| Low | 33 (26.6%) | 32 (66.7%) | 0.000 |
| Intermediate | 45 (36.3%) | 4 (8.3%) | |
| High | 46 (37.1%) | 12 (25.0%) | |
| Pulmonary hypertension | 38 (30.6%) | 25 (52.1%) | 0.013 |
| Albumin (g/dL) | 3.9 (3.6–4.1) | 3.8 (3.4–4.1) | 0.070 |
| LDL cholesterol (mg/dL) | 91.6±19.2 | 86.9±22.4 | 0.173 |
| HDL cholesterol (mg/dL) | 41.0 (35.3–48.8) | 37.0 (29.7–44.5) | 0.023 |
| Triglyceride (mg/dL) | 128.5 (98.5–159.2) | 117.3 (83.6–182.3) | 0.724 |
| ALP (IU/L) | 67.1 (58.1–88.5) | 71.6 (58.2–95.0) | 0.352 |
| Ca–P (mg2/dL2) | 44.4 (38.6–51.8) | 45.4 (36.5–50.1) | 0.424 |
| Hb (g/dL) | 10.3 (9.9–10.7) | 10.2 (9.8–10.7) | 0.586 |
| CRP (mg/L) | 2.15 (1.09–4.18) | 2.80 (1.25–5.75) | 0.087 |
All values are expressed as mean±standard deviation, number of patients (%), or median (confidence interval 25–75%).
ALP, alkaline phosphatase; BMI, body mass index; COPD, chronic obstructive lung disease; CRP, C-reactive protein; Hb, hemoglobin; HDL, high-density lipoprotein; LDL, low-density lipoprotein; SVCS, simple vascular calcification score.